Addus HomeCare (NASDAQ:ADUS) PT Raised to $145.00

Addus HomeCare (NASDAQ:ADUS) had its target price raised by Oppenheimer from $140.00 to $145.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target indicates a potential upside of 8.79% from the stock’s current price.

ADUS has been the topic of a number of other research reports. Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price target for the company. TD Cowen upped their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Stephens restated an “overweight” rating and set a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $141.00 target price on shares of Addus HomeCare in a report on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $128.29.

Addus HomeCare Stock Up 0.3 %

Shares of Addus HomeCare stock opened at $133.29 on Monday. The stock has a market capitalization of $2.41 billion, a price-to-earnings ratio of 33.07, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. Addus HomeCare has a twelve month low of $78.35 and a twelve month high of $136.12. The company has a 50-day simple moving average of $127.53 and a two-hundred day simple moving average of $114.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.94 earnings per share. On average, sell-side analysts anticipate that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at $429,165. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The disclosure for this sale can be found here. In the last ninety days, insiders sold 22,917 shares of company stock worth $3,050,082. Insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors have recently modified their holdings of the company. Charles Schwab Investment Management Inc. boosted its position in shares of Addus HomeCare by 7.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 179,635 shares of the company’s stock valued at $16,679,000 after purchasing an additional 12,392 shares in the last quarter. Principal Securities Inc. acquired a new stake in shares of Addus HomeCare during the 4th quarter worth approximately $26,000. Dimensional Fund Advisors LP increased its stake in shares of Addus HomeCare by 0.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 698,498 shares of the company’s stock valued at $64,857,000 after acquiring an additional 5,654 shares in the last quarter. Envestnet Portfolio Solutions Inc. acquired a new position in shares of Addus HomeCare during the 4th quarter valued at $214,000. Finally, Trexquant Investment LP bought a new position in Addus HomeCare during the fourth quarter worth $271,000. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.